BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15816544)

  • 1. Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line.
    Ansquer Y; Legrand A; Bringuier AF; Vadrot N; Lardeux B; Mandelbrot L; Feldmann G
    Anticancer Res; 2005; 25(1A):243-8. PubMed ID: 15816544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [BRCA1 regulates progesterone receptors A and B protein expressions in breast cancer cells in vitro].
    Guo YX; Zeng WS; Liu YW; Li YS; Lin J; Xiong JB; Luo SQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1157-60. PubMed ID: 18676251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
    Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
    Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1].
    Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD
    Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
    Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
    Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolocalization of BRCA1 protein in tumor breast tissue: prescreening of BRCA1 mutation in Tunisian patients with hereditary breast cancer?
    Troudi W; Uhrhammer N; Ben Romdhane K; Sibille C; Mahfoudh W; Chouchane L; Ben Ayed F; Bignon YJ; Ben Ammar Elgaaied A
    Eur J Histochem; 2007; 51(3):219-26. PubMed ID: 17921118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A inhibition of prolactin-dependent up-regulation of BRCA1 protein expression in human breast cell lines.
    Favy DA; Rio PG; Vissac C; Maurizis JC; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2000; 20(3A):1703-4. PubMed ID: 10928095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
    Toyama T; Yamashita H; Kondo N; Okuda K; Takahashi S; Sasaki H; Sugiura H; Iwase H; Fujii Y
    BMC Cancer; 2008 Oct; 8():309. PubMed ID: 18950515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones.
    Lee EY
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):68-73. PubMed ID: 18197009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
    Calvo V; Beato M
    Cancer Res; 2011 May; 71(9):3422-31. PubMed ID: 21531767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating progesterone effects in breast cancer: cross talk with PDGF signaling pathway in smooth muscle cell.
    Soares R; Guerreiro S; Botelho M
    J Cell Biochem; 2007 Jan; 100(1):174-83. PubMed ID: 16888808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
    Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
    Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
    Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
    Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [BRCA1 inhibits progesterone-induced proliferation and migration of breast cancer cells].
    Xiong J; Zhao J; Peng L; Wang H; Liang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Aug; 32(8):1105-10. PubMed ID: 22931600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate.
    Calcabrini A; García-Martínez JM; González L; Tendero MJ; Ortuño MT; Crateri P; Lopez-Rivas A; Arancia G; González-Porqué P; Martín-Pérez J
    Carcinogenesis; 2006 Aug; 27(8):1699-712. PubMed ID: 16624827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of telomerase activity after progesterone treatment of human breast cancer cells: essential role of the cell cycle status.
    Lebeau J; Fouchet P; Ory K; Chevillard S
    Anticancer Res; 2002; 22(4):2161-6. PubMed ID: 12174898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects.
    Rocha A; Azevedo I; Soares R
    J Cell Biochem; 2008 Feb; 103(2):607-14. PubMed ID: 17614352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.